M&A


Charles Schwab Wants to Provide Clients With Access to Private Assets. It’s Buying Forge Global.

The deal would enable Schwab to offer individual investors and financial advisors greater access to private markets at a time when more companies are electing to remain private.

Long Read

Go to article

No Tylenol-Kleenex Deal Might Be Best for Dividend Investors

Both Kimberly Clark and Kenvue are Dividend Aristocrats. Dividends after a merger could well disappoint.

3 minute read

Go to article

The AI Stocks Selloff Could Be a Bust or a Blip. This Will Decide Which.

AMD beats expectations, Mamdani wins NYC mayoral election, Bitcoin briefly dips below $100,000, and more news to start your day.

Long Read

Go to article

What Could Stop Kimberly-Clark’s Play for Kenvue

The deal is one of the worst-received major merger deals in recent years.

2 minute read

Go to article

Waverly Advisors Makes Back-to-Back Acquisitions. Assets Climb to $26 Billion.

The moves reflect this year’s record-breaking growth in M&A activity among registered investment advisors.

2 minute read

Go to article

Papa John’s Stock Tumbles on Report That Apollo Won’t Take Pizza Chain Private

Private-equity firm Apollo reportedly has backtracked on its bid because of concerns of weaker consumer spending on fast food, Reuters reported.

1 minute read

Go to article

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera

The Danish company’s latest offer is more than 30% about what Pfizer initially agreed to pay, not counting potential milestone payments.

Long Read

Go to article

Markets Face a Big Risk From This AI Spending Spree. What to Watch.

OpenAI strikes cloud computing deal with Amazon, Palantir CEO touts strong third-quarter results, Trump threatens to cut NYC funds, and more news to start your day.

Long Read

Go to article

Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal.

Kenvue shareholders will receive $21.01 a share under terms of the deal.

4 minute read

Go to article

Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera

Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political currents in its efforts to save the deal.

Long Read

Go to article

Private-Equity Firm Combines Businesses To Form Wealth Management Juggernaut

Newly reconstituted Wealthspire will have $580 billion in client assets in private accounts and retirement plans.

2 minute read

Go to article

Stifel CEO Bats Down Idea Company Is for Sale

CEO Ron Kruszewski expressed confidence in his company’s strategy.

2 minute read

Go to article

Netflix Is Weighing Up a Warner Bros. Bid, Report Says. Get Ready for a Bidding War.

The deal would feel the streaming giant's flywheel model, giving it even more content to attract subscribers.

2 minute read

Go to article

AssetMark to Acquire Advisory Platform With $3 Billion of Assets

AssetMark is buying Efficient Advisors, a turnkey asset management platform serving two hundred advisory practices.

2 minute read

Go to article

Amazon, Apple Were the Mag 7 Losers. Here’s Why That’s About to Change.

Apple is betting on a big holiday season, Netflix weighs Warner Bros. bid, Pfizer and Novo Nordisk find themselves in a bidding war, and more news to start your day.

Long Read

Go to article

Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks.

Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and regulatory milestones.

3 minute read

Go to article

Core Scientific Shareholders Reject Merger With CoreWeave

The merger drew the ire of several large shareholders, including Two Seas Capital.

1 minute read

Go to article

Morgan Stanley’s Latest Deal Highlights Wall Street’s Existential Bet on Private Markets

The bank is buying EquityZen, which promotes itself as a way to connect investors seeking private assets with shareholders of private companies.

2 minute read

Go to article

Firm Backed by Joe Duran's Rise Buys $2 Billion Wealth Management Practice

The addition of Spahn Financial Partners is the largest to date for OnePoint BFG Wealth Partners, which is backed by Joe Duran’s Rise Growth Partners.

2 minute read

Go to article

Nokia Stock Soars. Nvidia to Invest $1 Billion and Take 2.9% Stake.

Nvidia’s stake will boost the Finnish company’s ability to build connectivity solutions for AI.

1 minute read

Go to article

Skyworks and Qorvo Stocks Soar as the Apple Suppliers Create $22 Billion Chip Business

The two companies make high-performance radio frequency, analog and mixed-signal semiconductors.

1 minute read

Go to article

Amazon Is Cutting Jobs. Why That’s a Strong Sign for the AI Boom.

Qualcomm enters AI computing race, Texas emerges as banking M&A epicenter, suspension of food assistance during shutdown to hit economy, and more news to start your day.

Long Read

Go to article

How Texas Became a Hotbed of Banking M&A

U.S. banks keep finding new deals in Texas. Why execs can’t get enough of the “Texaplex.”

4 minute read

Go to article

Qualcomm, MP Materials, USA Rare Earth, Tesla, Avidity, Newmont, Microsoft, and More Stock Market Movers

Qualcomm soars after introducing new artificial-intelligence servers meant to compete with Nvidia and AMD, while MP Materials falls as Treasury Secretary Scott Bessent says he expects China to defer its tightened export controls on rare-earth materials.

3 minute read

Go to article

iRobot Stock Tumbles. It Can’t Find a Buyer.

The maker of automated vacuums made the statement in an 8-K.

1 minute read

Go to article

of 20 pages